BIYKEM BOZKURT to Immunosuppressive Agents
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Immunosuppressive Agents.
Connection Strength
0.301
-
Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints. J Cardiovasc Magn Reson. 2025; 27(1):101121.
Score: 0.161
-
Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. J Card Fail. 2002 Oct; 8(5):306-14.
Score: 0.140